GXH Stock Overview
Provides health care and advice services to communities in New Zealand. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Green Cross Health Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$0.83 |
| 52 Week High | NZ$1.30 |
| 52 Week Low | NZ$0.71 |
| Beta | 0.056 |
| 1 Month Change | 0% |
| 3 Month Change | 10.67% |
| 1 Year Change | -23.85% |
| 3 Year Change | -30.25% |
| 5 Year Change | -30.83% |
| Change since IPO | 72.92% |
Recent News & Updates
Here's Why Green Cross Health (NZSE:GXH) Has A Meaningful Debt Burden
Jul 24
Little Excitement Around Green Cross Health Limited's (NZSE:GXH) Earnings As Shares Take 29% Pounding
Jun 27Recent updates
Here's Why Green Cross Health (NZSE:GXH) Has A Meaningful Debt Burden
Jul 24Little Excitement Around Green Cross Health Limited's (NZSE:GXH) Earnings As Shares Take 29% Pounding
Jun 27There May Be Some Bright Spots In Green Cross Health's (NZSE:GXH) Earnings
Jun 06Green Cross Health (NZSE:GXH) Will Pay A Smaller Dividend Than Last Year
Jun 05Green Cross Health Limited's (NZSE:GXH) Share Price Is Matching Sentiment Around Its Earnings
Dec 24Green Cross Health (NZSE:GXH) Has Announced That Its Dividend Will Be Reduced To NZ$0.0294
Dec 03Green Cross Health (NZSE:GXH) Is Paying Out A Dividend Of NZ$0.0412
Nov 28Capital Allocation Trends At Green Cross Health (NZSE:GXH) Aren't Ideal
May 04Green Cross Health (NZSE:GXH) Share Prices Have Dropped 58% In The Last Five Years
Mar 14Is Green Cross Health Limited (NZSE:GXH) Popular Amongst Insiders?
Feb 12Has Green Cross Health (NZSE:GXH) Got What It Takes To Become A Multi-Bagger?
Jan 28Is Green Cross Health Limited's (NZSE:GXH) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 13Does Green Cross Health (NZSE:GXH) Have A Healthy Balance Sheet?
Dec 29Would Shareholders Who Purchased Green Cross Health's (NZSE:GXH) Stock Five Years Be Happy With The Share price Today?
Dec 14
We Think Green Cross Health's (NZSE:GXH) Statutory Profit Might Understate Its Earnings Potential
Nov 29Shareholder Returns
| GXH | NZ Consumer Retailing | NZ Market | |
|---|---|---|---|
| 7D | 1.2% | 0.3% | 0.6% |
| 1Y | -23.9% | -8.2% | 6.5% |
Return vs Industry: GXH underperformed the NZ Consumer Retailing industry which returned -8% over the past year.
Return vs Market: GXH underperformed the NZ Market which returned 6.7% over the past year.
Price Volatility
| GXH volatility | |
|---|---|
| GXH Average Weekly Movement | 8.5% |
| Consumer Retailing Industry Average Movement | 3.0% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in NZ Market | 8.7% |
| 10% least volatile stocks in NZ Market | 3.0% |
Stable Share Price: GXH's share price has been volatile over the past 3 months compared to the NZ market.
Volatility Over Time: GXH's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of NZ stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | n/a | Rachael Newfield | www.greencrosshealth.co.nz |
Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores.
Green Cross Health Limited Fundamentals Summary
| GXH fundamental statistics | |
|---|---|
| Market cap | NZ$119.19m |
| Earnings (TTM) | NZ$12.07m |
| Revenue (TTM) | NZ$513.61m |
9.9x
P/E Ratio0.2x
P/S RatioIs GXH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GXH income statement (TTM) | |
|---|---|
| Revenue | NZ$513.61m |
| Cost of Revenue | NZ$457.45m |
| Gross Profit | NZ$56.17m |
| Other Expenses | NZ$44.09m |
| Earnings | NZ$12.07m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.084 |
| Gross Margin | 10.94% |
| Net Profit Margin | 2.35% |
| Debt/Equity Ratio | 20.4% |
How did GXH perform over the long term?
See historical performance and comparisonDividends
4.8%
Current Dividend Yield54%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 06:10 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Green Cross Health Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hayden Brown | Jarden NZ |